Context-dependent interaction between oxytocin gene polymorphisms and alcohol dependence in modulating negative emotions during acute alcohol withdrawal in adult males
Validation of a criterion-based screening and triage pathway for adult ADHD: a prospective observational study of safety and operational efficiency
Protracted encephalopathy and subacute combined degeneration associated with chronic nitrous oxide use: a case report
Shifting the Overton Window: enhancing therapeutic outcomes for Māori experiencing Ngā Māuiui kai (eating disorders) through the integration of traditional Māori and Western healing systems in Aotearoa New Zealand
Guide DNA — not RNA — expands the CRISPR toolkit
Nature Biotechnology, Published online: 15 May 2026; doi:10.1038/s41587-026-03138-9
Cas12 nucleases can use guide DNA instead of guide RNA, which switches their targets from DNA to RNA.
Widespread DNA off-targeting confounds RNA chromatin occupancy studies
Nature Biotechnology, Published online: 15 May 2026; doi:10.1038/s41587-026-03130-3
Many long noncoding RNA–DNA binding peaks detected using common assays arise from technical artifacts.
DNA-guided CRISPR–Cas12 for cellular RNA targeting
Nature Biotechnology, Published online: 15 May 2026; doi:10.1038/s41587-026-03129-w
ΨDNA guides are used with Cas12 for precise, programmable targeting of cellular RNA.
What Galen’s dissections reveal about tacit learning in modern medical education
Nature Medicine, Published online: 15 May 2026; doi:10.1038/s41591-026-04412-8
What Galen’s dissections reveal about tacit learning in modern medical education
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
Nature Medicine, Published online: 15 May 2026; doi:10.1038/s41591-026-04402-w
An open-label, randomized controlled phase 2 trial comparing favipiravir with ribavirin for the treatment of mild-to-moderate Lassa fever in Nigeria found that favipiravir was safe and well tolerated and supports its further optimization as a treatment alternative.

